Citizens Financial Group Inc Leap Therapeutics, Inc. Transaction History

Citizens Financial Group Inc

  • $4.47 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020
SELL
$1.68 - $2.17 $8,232 - $10,633
-4,900 Closed
0 $0
Q1 2020

May 08, 2020
BUY
$1.06 - $2.94 $5,194 - $14,406
4,900 New
4,900 $8,000
Q4 2019

Feb 07, 2020
SELL
$0.63 - $1.37 $7,159 - $15,570
-11,365 Closed
0 $0
Q3 2019

Nov 01, 2019
BUY
$1.17 - $2.36 $13,297 - $26,821
11,365 New
11,365 $13,000

Others Institutions Holding LPTX

# of Institutions
1
Shares Held
265K
Call Options Held
0
Put Options Held
0
View Full List

About LEAP THERAPEUTICS, INC.

LPTX Quotes by TradingView
  • Ticker LPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,021,400
  • Market Cap $239M
  • Description
  • Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...
More about LPTX
Track This Portfolio

Track Citizens Financial Group Inc Portfolio

Follow Citizens Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email